Article info

PDF

Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study

Authors

  1. Correspondence to Professor Naga Chalasani; nchalasa{at}iu.edu
View Full Text

Citation

Vilar-Gomez E, Athinarayanan SJ, Adams RN, et al
Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study

Publication history

  • Received April 16, 2018
  • Revised November 28, 2018
  • Accepted November 30, 2018
  • First published February 25, 2019.
Online issue publication 
February 25, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.